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1. Introduction 
In early breast cancer, the presence of metastasis in axillary lymph nodes is an important 
factor in prognosis and further treatment. However, axillary lymph node dissection causes 
many complications such as contracture of the shoulder joint, lymph edema, and paralysis 
of the upper extremities (Ernst, 2002). Convention holds that there is no need to dissect 
axillary lymph nodes for node-negative patients. To avoid unnecessary axillary lymph node 
dissection, sentinel node biopsy (SNB) has been performed (Veronesi, 1997; Schrenk, 2000). 
Sentinel node (SN) is defined as the first lymph node drained of lymph flow from the tumor 
(Schwartz, 2002; Kuehn, 2005). SNB can detect such metastases and provide information that 
may obviate the need for axillary lymph node dissection. The most commonly used 
methods to identify the SN are dye-staining (Giuliano, 1994; Borgstein, 1997) and 
radioisotope incorporation (Krag, 1993; Giuliano, 1994). Multidetector-row three-
dimensional computed tomography (3D-CT) mammary lymphography (LG) can be used to 
mark the precise location of the SN on the skin before the operation (Suga, 2003; Tangoku, 
2004; Minato, 2004). 
The detailed relations between lymph nodes and lymph flow in the breast and the axilla can 
be clarified using 3D-CT LG (Yamashita, 2008, 2009). We have developed this 3D image 
processing system to depict more precise anatomical structure of mammary lymphovascular 
system. It enables us to perform systematic collection of axillary lymph nodes including 
SNs, and will decrease unnecessary lymph node dissection, even if the SNs have 
metastasized, and can decrease complications.  
Previously, we devised an endoscopic surgical procedure for breast diseases; video-assisted 
breast surgery (VABS) (Yamashita, 2006). VABS is a less invasive and esthetically a better 
operation for benign and malignant breast diseases In this study, we assessed the validity of 
3D-CT LG in SNB of 186 patients, investigated the extent of metastasis style in 40 patients 
who were metastasis-positive based on the novel technique, and applied the technique to 
SNB using the dye-staining method and 3D-CT LG guidance.  
2. Patients 
Since July 2002, SNB was performed in 186 patients, with SNB using VABS and 3D-CT LG 
being performed in 146 of these. Patient characteristics are shown in Table 1. 
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 Mean Range 
Age (y/o) 52.7 26 – 85 
Tumor size (cm) 2.2 0.1 – 10 
 Number % 
Tis 3 1.6 
T1a / T1b / T1c 3 / 20 / 86 1.6 / 10.8 / 46.2 
T2 / T3 / T4 53 / 9 / 12 28.5 / 4.8 / 6.5 
Lymph node metastasis (N) 40 21.5 
Distant metastasis (M) 9 4.8 
ER  (+/-) 122 / 64 65.6 
PgR (+/-) 98 / 88 52.7 
HER2 (+/-)a 44 / 142 23.7 
Total 186  
ER, estrogen receptor; PgR, progesterone receptor; HER, human epidermal growth factor receptor 
a Modified from reference 14. 
b HER2: human epidermal growth factor receptor type 2; HER2 + means Herceptest 3+ and 2+; HER2 – 
means Herceptest 1+ and 0 
Table 1. Patient Characteristics a 
3. 3D-CT lymphography 
Interstitial 3D-CT LG was performed using a 16-channel multidetector-row helical 3D-CT 
scanner (Toshiba Aquilion 16; Toshiba Medical Systems Corporation, Tochigi, Japan). 
Patients were placed in the supine position with arms positioned in the lateral abduction 
direction, suitable for the operating position. After local anesthesia by subcutaneous 
injection of 0.5 ml of 1% lidocaine, 2 ml of iopamidol (Iopamiron 300; Nihon Shering, 
Osaka, Japan) was injected intracutaneously into the periareolar skin and the skin above 
the tumor. At 1 and 3 min after injection (sometimes 5 min for observing advancement of 
lymph flow), a CT image was taken with a 3 mm slice thickness. SNs were identified on 
transaxial CT images, and their location was marked on the skin surface with an oil-
painting pen using a laser pointer of CT on the day before the surgery. 3D-CT images 
were then reconstructed from transaxial enhanced CT images, which clearly showed the 
lymph ducts and SNs. 
4. SPECT 
On the day before surgery, 74 MBq technetium 99m (99mTc) phytate (FUJIFILM RI Pharma 
Co., LTD., Tokyo, Japan) in sterile saline (total volume 1 mL) was injected intradermally into 
two different sites of the skin above the tumor and around the periareola. 
Lymphoscintigraphy and SPECT were performed 2 hours after injection of radio colloid. If 
one or more focal accumulations of radioactivity (hot spots) were visualized, these were 
assumed to be SNs. Small amount of RI markers were positioned on the jagular notch of 
sternum and the xiphoid process to correct the fusion points. We used the image fusion 
software Syntegra (Philips Medical Systems, Eindhoven, The Netherlands) and Real 
INTAGE (KGT, Tokyo, Japan) to fuse SPECT data with 3D-CT LG. 
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5. Surgical methods 
VABS has been described in detail previously (Yamashita, 2006). The operative procedures 
were as follows: skin incision in the axilla and/or periareola, skin flap formation via the 
tunnel method (Yamagata, 2002), pectoral muscle fascia dissection, vertical section of the 
mammary gland, SNB by the dye-staining method guided by preoperative 3D-CT LG 
marking, and axillary lymph node dissection (levels I and II). Radiotherapy and 
chemotherapy were performed for malignant diseases. 
SLNB was performed by the dye-staining method using a part of VABS technique at the 
beginning of the operation, before gland resection. In the periareolar region and over the 
tumor, 2 ml of 1% indocyanine green was injected subcutaneously. A 1-cm long skin 
incision was made along wrinkles in the axilla at the position marked by 3D-CT LG. A 
Visiport optical trocar (Tyco Healthcare Japan, Tokyo, Japan) was inserted into the incision 
after 20 min. The endoscopic view was observed through Visiport with a 10 mm diameter, 
straight-angled rigid endoscope (Olympus Optical, Tokyo, Japan), and the stained lymph 
nodes were found by following the dye in the lymph ducts. The lymph nodes were sampled 
and metastasis was determined on fast frozen sections. Axillary lymph node dissection was 
performed at levels I and II with bipolar scissors through the same incision that was 
lengthened to 2.5 cm. The inferior pectoral nerve, long thoracic nerve, second and third 
intercostobrachial nerves, thoracodorsal nerve, artery, and vein were observed and 
preserved. The lateral pectoral artery was preserved for the lateral tissue flap. After surgery, 
SNs and axillary lymph nodes were pathologically examined by standard H&E staining.  
Informed consent to the procedure was obtained from all the patients before surgery. 
6. Lymph flow from tumor to sentinel node (Yamashita, 2008) 
The lymph flow of the whole breast has been reported to collect into a subareolar plexus and 
then drain towards the axilla via lymph collecting ducts, by human cadaver studies 
(Delamere, 1993; Standring, 2005). It became the theoretical basis for the subareolar injection 
of dye and/or isotope for lymphatic mapping as part of the SN biopsy for breast cancer 
(Kimberg, 1999; Kern, 1999). On the other hand, the individual lymphatic flow is not 
identical in each living patient studies of SN biopsy. 
3D-CT LG showed the precise lymphatic flow from the tumor to the SN (Fig. 1). In Figure 
1a, the lymphatic flow from the tumor was divided to the periareola and directly to the 
axilla. The periareolar lymphatic flow was draining from the tumor and circling around the 
nipple and went to the axilla. This lymph duct to the axilla was separated from the direct 
duct from the tumor. In Figure 1b, the lymphatic flow was multiple and complicated, but 
the basic structure was same as that of Fig. 1a. 
We classified the relationship between the lymph ducts and drained SNs into four patterns 
(Yamashita, 2008) (Fig. 2), according to the classification by Suga et al. (Suga, 2005). A single 
duct to single node pattern was observed in 88 cases (60.2%), multiple ducts to a single node 
in 29 cases (19.9%), single duct to multiple nodes in two cases (1.4%), and multiple ducts to 
multiple nodes in 27 cases (18.5%). 
The internal mammary SN was also detected in five patients, but the rate was lower than 
that of the peritumoral injection (Shimazu, 2003). We are trying to improve it by the 
injection of the contrast medium iopamidole into the retromammary space behind the 
tumor. The peritumoral injection, which is recommended in radioisotope technique, is not 
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suitable for 3D-CT LG, because the contrast medium is needed to use much volume as 1 ml 
and it may flow into surrounding mammary duct systems. 
 
 
Fig. 1. Visualization of SNs and lymph ducts (LD) using 3D-CT LG (13).  
Iopamidol was injected intracutaneously into the periareolar skin and the skin above the 
tumor. a) Two LDs draining into two SNs. b) Multiple LDs draining into a single SN. 
 
 
Fig. 2. Four patterns of relationship between the lymph duct and the sentinel lymph node 
(Yamashita, 2009). 
The lymph flow pattern can be classified into these four types. 
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SN is typically detected using dye-staining or radioisotope incorporation. However, the tract 
from the tumor to the SN cannot be observed clearly by either methods (Mariani, 2001; 
Giuliano, 1997). We cannot detect whether dye-stained or hot-spotted nodes are really the first 
lymph nodes. This may be the basis for false negatives in SN biopsy. Lymphoscintigraphy 
may only show the main negative lymph node, and cannot clearly visualize the direct 
connection of SN and their afferent lymph ducts, because of slow lymphatic migration  
of radiocolloids, and because of the limitation of spatial resolutions and the lack of anatomic 
landmarks. In contrast, 3D-CT LG can demonstrate the precise route of the lymph duct and the 
exact location of the SN with the detailed surrounding anatomic structures, and since it  
does not involve the use of radioisotopes, it can be done at any institution that is equipped 
with a CT scanner. Therefore, 3D-CT LG is a very useful examination, which is essential  
for SNB. 
Interstitial injection of iopamidol had no adverse effects locally and generally. The 
pathological metastatic status of SNs and axillary lymph nodes was as follows. No SN was 
identified in five patients of the 40 SNBs using only the dye-staining method, and the 
detection rate was 87.5%. However, all SNs were identified in 146 SNBs using the dye-
staining method with 3D-CT LG marking. This detection rate was 100%. Backup axillary 
dissection was performed in each of the 40 SNB patients in the early phase according to both 
methods of SNB. One false-negative case occurred only in the dye-staining method (12.5%), 
but no false-negative case was found in 3D-CT LG (0%). The average sampled number of 
SNs was 1.7 in the cases without 3D-CT LG and 2.3 in the cases with 3D-CT LG. 
Four patterns of lymph ducts and SNs have been revealed using 3D-CT LG (Yamashita, 
2008). The lymph ducts to the SN are complicated. For example, in this study, we observed 
that in over 60% of cases, many ducts joined together into a single duct to form a single SN. 
However, more than two SNs were shown in 19.9% of the cases. These may have been 
missed without 3D-CT LG guidance. Figure 4a shows a typical example of a multi-node 
pattern, in which three different lymph nodes were all SN, each from a different lymph 
duct. The node from the main thick duct was not metastasized; however, the other two from 
the narrow collateral duct were metastasized. Thus, the sampling of all three nodes is 
necessary. The dye-staining method and the isotope method of SNB could not reach such 
the latter collateral nodes. These might become false negative study. Therefore, 3D-CT LG is 
effective in raising accuracy of SNB. 
7. Lymph flow from sentinel node to axillary angle in axilla (Yamashita, 2009) 
The procedure of 3D-CT LG takes only about 1 min after injection of iopamidol 
subcutaneously over the tumor and around the nipple for representing SN precisely. 
Examination of iopamidol flow 1, 3, and 5 min after injection revealed that the flow extended 
over the SN into the next nodes, and into the venous angle in half of the patients examined. 
Therefore, we can easily ascertain the tracts that cancer cells will spread through during 
metastasis. We defined these tracts as the second and third SNs. As a representative example, 
Fig. 3 shows a clear view of five bead-like grouped lymph nodes beyond the SN into the center 
of the body, and lymph duct plexuses between them. They are thought to imply the order of 
lymphatic route of metastasis. Fig. 4a shows three separated SNs, which were drained from 
three different lymph ducts diverging from one duct. Two of three separated SNs were 
positive for metastasis, but the other SNs from the main lymph duct were negative. Fig. 4b 
shows two chained SNs. The first SN was positive for metastasis, but the second was negative. 
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Fig. 3. Chronological examination of 3D-CT LG (Yamashita, 2009). 
3D-CT LG was examined 1, 3, and 5 min after iopamidol injection. Iopamidol flowed to 
extend over the SN into the next nodes. Five bead-like grouped lymph nodes in the axilla 
can be visualized by partially removing the pectoral muscle in the CT monitor.  
These are thought to be the order of lymph metastasis. Arrows point to lymph nodes  
1–5 after SN. 
Since December 2001, we performed VABS in 230 patients, SN biopsy in 186 patients, and 
3D-CT LG in 140 patients. Table 2 shows the pathological status of metastases in SNs and 
axillary lymph nodes. SN metastasis was positive in 40 patients; of these, 21 patients 
experienced metastases solely in the SN. Except for SN, only the second axillary lymph node 
group was metastasized in three patients, the second and the third node groups were 
metastasized in five patients, and more than three groups were metastasized in eleven 
patients. It was confirmed that these metastases occurred in order of lymph flow presented 
by the lymphoid path of these 3D-CT LG (Fig. 3, 4).  
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Fig. 4. Detection of SN metastasis (Yamashita, 2009). 
a) Three sentinel nodes are recognized by 3D-CT LG. The right node drained from the main 
lymph duct was not metastasized. On the other hand, the other two nodes drained from the 
narrow collateral duct were metastasized. Dye and isotope could not reach such the latter 
collateral nodes. These might become false negative study. Therefore, 3D-CT LG is effective 
in raising accuracy of SNB. 
b) The sentinel node was metastasized, but the second node and the other nodes were all 
negative.  
The second and third lymph nodes groups could be recognized by 3D-CT LG and 
selectively removed by VABS. Table 2 shows the pathological status of their metastases and 
the other axillary lymph nodes in 40 SN metastasized patients. If second and third lymph 
node group biopsy was performed, it was prognostic for other axillary lymph node 
metastasis. Its accuracy, sensitivity, and false negative rate were 100%, 100%, and 0%, 
respectively. 
 
Status of 2
nd
 and 3
rd
 Sentinel LN 
metastasis 
Status of Axillary LN metastasis* 
Negative Positive 
Positive 19 8 11 
Negative 21 21 0 
Total 40 29 11 
Table 2. Metastatic relations of 2nd and 3rd SN to the other axillary nodes a  
LN: lymph node 
* Number of Axillary LN metastasis: Primary, and 2nd, and 3rd Sentinel LN is not included. 
2nd and 3rd Sentinel LN biopsy: Accuracy = 100 %, False negative rate = 0 %, Sensitivity = 
100 % 
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Even if the patients presently examined had metastasis of SN, about half of them had no 
metastasis in axillary lymph nodes (21 among 40 patients, 52.5% in Table 3). In these 
patients presenting with only SN metastasis, sufficient information can be obtained 
regarding the lymph node status of cancer staging to plan primary therapy after surgery, 
avoiding axillary lymph node dissection. Since the absence of other metastases is crucial 
to this approach, we need to analyze how it would be possible to conclude that  
SLN metastasis is unique. We suggest that this can be confirmed by collecting lymph 
nodes systemically based on the 3D-CT LG-acquired map of lymph nodes and ducts 
beyond SN. Histological examination of fast-frozen sections of the second and third 
lymph nodes during the operation will provide the information to omit axillary lymph 
node dissection. 
 
Sentinel LN metastasis 
No. of Axillary LN metastasis* 
2
nd
 3
rd
 4
th
< Sum 
Positive 40 19 16 11 19 
Negative 141     
Not detected 5 0 0 0 0 
Total 186 19 16 11 19 
Table 3. Metastatic status of sentinel and the other axillary nodes 
a Detection rate 97.3％  (without 3D-CT 88% / 40,  with 3D-CT  100% /146 
 Average LN number  2.0,   Only SLN metastasis 21 (52.5%) 
LN: lymph node, 3D-CT: 3-dimensional computed tomography, LG: lymphography 
* Axillary LN metastasis: Sentinel LN is not included* 
8. Metastatic evaluation by 3D-CT LG  
3D-CT LG may predict whether SN is metastasizing or not. When occupied with cancer 
cells, 3D-CT LG shows only the trumpet-like inflow portion of the lymph node, but the node 
is still recognizable. Sometimes, the lymph duct detours around the metastasized lymph 
node. However, in partial metastasis of the lymph node, 3D-CT LG shows no apparent 
difference from normal nodes. We have to examine the pattern of the duct route and the 
enhanced pattern of lymph node more carefully to predict metastasis. Ultrasonography and 
magnetic resonance imaging show only morphology and blood flow, and cannot reveal 
metastasis. While positron emission tomography can detect some metastases, those that are 
small escape detection. Of all these techniques, 3D-CT LG is superior. 
9. Endoscopic SNB guided by 3D-CT LG 
We have performed endoscopic surgery, named as video-assisted breast surgery (VABS), for 
all breast surgical procedures through a small wound port in the inconspicuous axillary area 
or periareola (Yamashita 2006a, 2006b). VABS is also used for SNB. The incisional wound is 
only 1 cm long and inconspicuous, without any complications. However, precise 
information is needed about the location of SN, because the method relies on endoscopic 
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vision. In five cases, we could not find the SLN using just only the dye-staining method. 3D-
CT LG guidance helps in finding the SN easily by giving precise information. The structure 
of the dye-stained lymph ducts and SN were exactly the same on the endoscopic view as 
with the 3D-CT LG. 
The lymph ducts to the SN are complicated. In most cases, many ducts join together into a 
single duct to a single SN (60.6 %). However, more than two SNs were shown in 19.7%, and 
these may have been missed without 3D-CT LG guidance, and hence 3D-CT LG is 
indispensable for SNB. 
10. SPECT-CT 
SPECT-CT can show the exact location of the hot spots on the axial view of the CT image, as 
showing in the figure (Fig. 5). They are always coincided with the axillary nodes. However, 
it cannot show the lymph ducts and the relations between lymph ducts and nodes either. 
The number of hot spots was usually only one or two. The average number was 1.2, which 
was less than the number 2.3 of SN found by 3D-CT LG. 
 
 
Fig. 5. Lymphoscintigraphy and SPECT-CT 
a. Lymphoscintigraphy  
The conventional lymphoscintigraphy shows only information about the existence of nodes 
with an uptake of RI as hot spots  
b. Single photon emission computed tomography (SPECT) 
SPECT-CT can show the exact location of the hot spots on the axial view of the CT image, as 
showing in the figure. They are always coincided with the axillary nodes. 
SN: sentinel node 
We fused the DICOM data of SPECT with 3D-CT LG by using the image fusion software 
(Fig. 6). The hot spot can be coincided with enhanced SN observed on 3D-CT LG. However, 
not all of SNs had a hot spot. We call SN with a hot spot as a hot node and SN without a hot 
spot as a cold node. We can recognize the location of the cold nodes by using the relation to 
the hot nodes on the map of 3D-CT LG. 
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Fig. 6. 3D-CT lymphography and SPECT-fused 3D-CT LG 
a. 3D-CT lymphography (LG) 
The contrast enhancing materials flow from the injected sites over the tumor and the 
periareola through the two lymph ducts into single SN in the axilla. 
b. SPECT-fused 3D-CT LG 
DICOM data of SPECT was projected on 3D-CT LG. The hot spots were coincided with SN 
detected by 3D-CT LG. 
11. Conclusion 
By 3D-CT LG, we can recognize the accurate and more precise lymph flow in the breast and 
the axilla. Even in patients with SN metastasis, if we find no metastatic presence in the 
second and third SN, the need to dissect more nodes is obviated. In the near future, it will be 
necessary to omit axillary dissection in such patients. 
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